Filing Details

Accession Number:
0001209191-11-058219
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2011-11-28 18:02:03
Reporting Period:
2011-11-01
Filing Date:
2011-11-28
Accepted Time:
2011-11-28 18:02:03
Original Submission Date:
2011-11-02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816284 Celgene Corp CELG Pharmaceutical Preparations (2834) 222711928
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405288 A Jacqualyn Fouse 86 Morris Avenue
C/o Celgene Corp.
Summit NJ 07901
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-11-01 1,000 $63.92 8,085 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. This form is being filed to amend the Form 4 filed on 11/02/2011 to correct the transaction code.